Enhancing Capital LLC purchased a new position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,133 shares of the company's stock, valued at approximately $292,000.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CTVA. Los Angeles Capital Management LLC acquired a new stake in Corteva during the 3rd quarter worth about $205,000. Thrivent Financial for Lutherans lifted its holdings in shares of Corteva by 16.1% in the 3rd quarter. Thrivent Financial for Lutherans now owns 1,025,266 shares of the company's stock valued at $60,275,000 after buying an additional 141,898 shares during the period. Quest Partners LLC acquired a new position in shares of Corteva in the 3rd quarter valued at about $587,000. Pathstone Holdings LLC lifted its holdings in shares of Corteva by 3.0% in the 3rd quarter. Pathstone Holdings LLC now owns 98,919 shares of the company's stock valued at $5,815,000 after buying an additional 2,846 shares during the period. Finally, Prospera Financial Services Inc lifted its holdings in shares of Corteva by 3.5% in the 3rd quarter. Prospera Financial Services Inc now owns 6,687 shares of the company's stock valued at $393,000 after buying an additional 226 shares during the period. Institutional investors and hedge funds own 81.54% of the company's stock.
Insider Activity
In related news, insider Brian Titus sold 26,560 shares of the company's stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $63.74, for a total value of $1,692,934.40. Following the transaction, the insider now directly owns 11,347 shares in the company, valued at approximately $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.20% of the company's stock.
Analyst Ratings Changes
Several equities analysts have recently issued reports on CTVA shares. Royal Bank of Canada boosted their price objective on Corteva from $72.00 to $73.00 and gave the company an "outperform" rating in a report on Friday, February 7th. Barclays boosted their price objective on Corteva from $62.00 to $64.00 and gave the company an "equal weight" rating in a report on Tuesday, January 21st. UBS Group decreased their price objective on Corteva from $74.00 to $73.00 and set a "buy" rating for the company in a report on Friday, January 10th. The Goldman Sachs Group assumed coverage on Corteva in a research note on Thursday, March 13th. They issued a "buy" rating and a $71.00 price target for the company. Finally, Oppenheimer lifted their price target on Corteva from $70.00 to $72.00 and gave the company an "outperform" rating in a research note on Friday, February 7th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $68.00.
View Our Latest Analysis on Corteva
Corteva Price Performance
NYSE:CTVA traded down $0.13 during trading hours on Friday, hitting $61.70. 6,880,464 shares of the stock were exchanged, compared to its average volume of 3,049,251. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The firm's fifty day moving average price is $62.44 and its 200 day moving average price is $59.87. The company has a market cap of $42.30 billion, a P/E ratio of 47.83, a P/E/G ratio of 1.68 and a beta of 0.79. Corteva, Inc. has a 52-week low of $50.01 and a 52-week high of $66.24.
Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. As a group, equities research analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Monday, March 3rd were given a $0.17 dividend. The ex-dividend date was Monday, March 3rd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.10%. Corteva's dividend payout ratio (DPR) is presently 52.71%.
Corteva Profile
(
Free Report)
Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.
See Also
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
